Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -276,852 | -356,388 | -348,995 | -284,002 | -200,042 |
| Depreciation Amortization | 10,640 | 7,321 | 15,192 | 13,296 | 5,931 |
| Income taxes - deferred | -155 | -1,415 | N/A | -167,305 | -3,742 |
| Accounts receivable | -11,219 | -11,114 | -13,294 | -7,725 | -1,419 |
| Other Working Capital | -32,064 | 11,610 | -4,727 | -23,997 | 1,522 |
| Other Operating Activity | 76,360 | 99,570 | 51,869 | 256,038 | 47,603 |
| Operating Cash Flow | $-233,290 | $-250,416 | $-299,955 | $-213,695 | $-150,147 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,352 | 115,165 | -114,892 | -166,715 | 1,442 |
| PPE Investments | -3,227 | -20,012 | -6,308 | -4,526 | -5,951 |
| Investing Cash Flow | $-13,579 | $95,153 | $-121,200 | $-171,241 | $-4,509 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 385,929 | N/A | 146,596 | N/A | 272,536 |
| Debt Repayment | -155,325 | -420 | -334 | -308 | -80,193 |
| Common Stock Issued | 42,282 | 201,282 | 307,345 | 259,338 | 100,104 |
| Common Stock Repurchased | -10,028 | -3,235 | -2,832 | -1,596 | -1,282 |
| Other Financing Activity | 0 | 19,875 | 0 | -10,000 | -18,450 |
| Financing Cash Flow | $262,858 | $217,502 | $450,775 | $247,434 | $272,715 |
| Exchange Rate Effect | 3,830 | 1,729 | 1,518 | 1,326 | -131 |
| Beginning Cash Position | 146,343 | 82,375 | 51,237 | 187,413 | 69,485 |
| End Cash Position | 166,162 | 146,343 | 82,375 | 51,237 | 187,413 |
| Net Cash Flow | $19,819 | $63,968 | $31,138 | $-136,176 | $117,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -233,290 | -250,416 | -299,955 | -213,695 | -150,147 |
| Capital Expenditure | -3,227 | -20,012 | -6,308 | -4,526 | -5,951 |
| Free Cash Flow | -236,517 | -270,428 | -306,263 | -218,221 | -156,098 |